Hvidovre, Denmark

Mikael S Thomsen

USPTO Granted Patents = 11 

 

 

Average Co-Inventor Count = 2.7

ph-index = 2

Forward Citations = 7(Granted Patents)


Location History:

  • Hridovre, DK (2019)
  • Hvidovre, DK (2015 - 2024)

Company Filing History:


Years Active: 2015-2024

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Mikael S Thomsen

Introduction

Mikael S Thomsen is a notable inventor based in Hvidovre, Denmark. He has made significant contributions to the field of pharmaceuticals, holding a total of 11 patents. His work focuses on developing innovative formulations that address various medical conditions.

Latest Patents

Among his latest patents are two noteworthy inventions. The first is a controlled release formulation that combines the active compounds tesofensine and a beta blocker, such as metoprolol or carvedilol. This invention is aimed at treating diabetes, obesity, or obesity-associated disorders. The second patent involves a composition comprising suplatast tosilate, which is intended for treating cough associated with interstitial lung disease, including conditions like pulmonary fibrosis.

Career Highlights

Mikael has worked with several companies throughout his career, including Saniona A/S and Contera Pharma ApS. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in pharmaceutical formulations.

Collaborations

Mikael has collaborated with notable professionals in his field, including Peter G Nielsen and Bent Højgaard. These partnerships have further enhanced his research and development efforts.

Conclusion

Mikael S Thomsen's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through his inventive formulations. His work continues to impact the treatment of various medical conditions, showcasing the importance of innovation in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…